2024
|
G/S
|
Pharmaceutical preparations and substances.. |
|
G/S
|
Pharmaceutical preparations for the treatment of of bone diseases, metabolic diseases, and cancer... |
|
G/S
|
Pharmaceutical preparations for the treatment of bone diseases, metabolic diseases, and cancer an... |
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparatio... |
|
G/S
|
Medicines and pharmaceutical preparations for the treatment of mental illness; antidepressants. |
|
G/S
|
Pharmaceutical preparations for the treatment of bone diseases, metabolic diseases, cancer, and c... |
|
G/S
|
Pharmaceutical preparations for the treatment of bone diseases, metabolic diseases, and cancer, a... |
|
G/S
|
Pharmaceutical preparations and substances. |
|
Invention
|
Reusable surgical training applicator for subdermal implants. An applicator device for training m... |
|
G/S
|
A medicine containing ferments. |
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
G/S
|
Anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for treatment of autoi... |
2023
|
G/S
|
Pharmaceutical preparations for the treatment of allergic rhinitis. |
|
G/S
|
Pharmaceutical preparations for bone diseases, metabolic diseases, and cancer and complications a... |
|
G/S
|
Fertility enhancement preparations for human use; pharmaceutical preparations for stimulating hum... |
|
G/S
|
Pharmaceutical preparations for stimulating human fertility. |
2013
|
Invention
|
S-mirtazapine for the treatment of hot flush.
The invention provides a method of treatment of ho... |
2012
|
Invention
|
Selective enzymatic amidation of c-terminal esters or acids of peptides.
The present invention r... |
2011
|
Invention
|
Isoxazole derivatives used as oestrogen modulators. The present invention relates to a substitute... |
|
Invention
|
Method for dosing a fluid formulation containing a medicinal substance. The present invention per... |
2010
|
Invention
|
Dihydrobenzoindazoles. The invention relates to benzoindazole derivatives according to general Fo... |
|
Invention
|
Hydroxyasenapine compounds, derivatives thereof and pharmaceutical compositions comprising same. ... |
|
Invention
|
Ring-annulated dihydropyrrolo[2,l-a]isoquinolines. The invention relates to ring-annulated dihydr... |
|
Invention
|
Fully human antibodies to btla. The present invention relates to binding compounds specific for B... |
|
Invention
|
Apparatus and method of preserving mucosa. A mixing apparatus (1) for mixing slaughter offal with... |
|
Invention
|
Dihydroimidazoisoquinoline derivatives useful as pde10 inhibitors. The present invention relates ... |
|
Invention
|
2-(1,2-benzisoxazol-3-yl)benzylamine derivatives. The invention relates to 2-(1,2-benzisoxazol-3-... |
|
Invention
|
Injectable formulations containing asenapine and method of treatment using same. The present inve... |
|
Invention
|
16,17-carbocyclic condensed steroid compounds having selective estrogenic activity.
The inventio... |
|
Invention
|
Substituted 16,17-annellated steroid compounds for use in women's healthcare. The present inventi... |
|
Invention
|
(dihydro) imidazoiso (5, 1-a) quinolines as fsh receptor agonists for the treatment of fertility ... |
|
Invention
|
Intrauterine system for use in medical treatment. An intrauterine system (1) is disclosed for use... |
|
Invention
|
Intrauterine system. An intrauterine system is disclosed for use in the treatment of dysfunctiona... |
|
Invention
|
Process to form an orally disintegrating tablet for human use. The present invention pertains to ... |
|
Invention
|
Process for the preparation of 7 alpha-methylsteroids.
The invention relates to a process for th... |
|
Invention
|
Indane derivatives. The present invention relates to anindane derivative according to formula I w... |
|
Invention
|
Tetrahydronaphthalen-2-ol derivatives. The present invention relates to novel tetrahydronaphthale... |
|
Invention
|
Tricyclic heterocyclic derivatives. The present invention relates to a tricyclic heterocyclic der... |
|
Invention
|
Antibodies against a proliferating inducing ligand (april). The present invention relates to a bi... |
|
Invention
|
Isoxazole-5-carboxamide derivatives. The present invention relates to isoxazole-5-carboxamide der... |
|
Invention
|
Isoxazole-3-carboxamide derivatives. The present invention relates to isoxazole-3-carboxamide der... |
|
Invention
|
6-phenyl-lh-imidazo [4, 5-c] pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin ... |
2009
|
Invention
|
1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agoni... |
|
Invention
|
1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives. The invention relates to 1-(4-(pyr... |
|
Invention
|
( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain. The invention relates to... |
|
Invention
|
1-(4-ureidobenzoyl)piperazine derivatives. The present invention relates to 1-(4-ureidobenzoyl)pi... |
|
Invention
|
Child resistant package. A package is formed by a sleeve, first and second members slideably moun... |
|
Invention
|
Indane derivatives as ampa receptor modulators. The present invention relates to a heterocyclic d... |
|
Invention
|
16alpha-methyl or ethyl substituted estrogens.
The invention makes a 16α-substituted steroidal c... |
|
Invention
|
Delivery system for paliperidone. This invention relates to an extended release formulation compr... |
|
Invention
|
N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivati... |
|
Invention
|
Package for medical product. A package (100) comprising a plurality of external panels (2) mutual... |
|
Invention
|
Purification of protein hydrolysate and the resultant products. The present invention relates to ... |
|
Invention
|
Pyrrolo[2,3-d]pyrimidin-2-yl-amine derivatives as pkc-theta inhibitors. The present invention rel... |
|
Invention
|
Preparation of a pharmaceutical composition for increasing bone mineral density. The present inve... |
|
Invention
|
Use of etonogestrel for benign prostate hyperplasia (bph).. The invention provides for the use of... |
|
Invention
|
(dihydro)pyrrolo[2,1-a]isoquinolines. The invention relates to 5,6 - dihydropyrrolo [2,1-a] isoqu... |
2008
|
Invention
|
Process for the preparation of asenapine and intermediate products used in said process. The inve... |
|
Invention
|
Method for the production of modified steroid degrading microorganisms and their use.
A method i... |
2007
|
Invention
|
Delivery system for risperidone.
This invention relates to an extended release formulation compr... |
|
Invention
|
Vaginal delivery system for mirtazapine.
This invention relates to an extended release formulati... |
|
Invention
|
Delivery system for a non-steroidal non-ionized hydrophilic drug.
This invention relates to an e... |
|
Invention
|
Drug delivery device.
A dispenser for administering a pharmaceutical substance in the form of a ... |
2006
|
Invention
|
Plexin d1 as a target for tumor diagnosis and therapy.
The present invention relates to plexin D... |
|
Invention
|
Steroids having a mixed androgenic and progestagenic profile.
The invention provides for compoun... |